|
In early November, we sent you trading ideas for flu season. In fact, we said, “Just last year, the US CDC estimates there were 35 million to 65 million flu illnesses, 16 million to 30 million flu-related medical visits, 390,000 to 830,000 flu-related hospitalizations and 25,000 to 72,000 flu-related deaths. All of which we could easily see again this year,” we added. Today, we’re learning the 2025 flu season is the most intense it’s been in 15 years. “So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths — including at least 57 children. Traditionally, flu season peaks around February. Overall, 43 states reported high or very high flu activity last week. Flu was most intense in the South, Southwest and western states.” This stock is driving innovation in the wound care space and recently announced a significant patent. This is the first and only patent granted for use in tabular fenestrated allografts, which will support the company’s commercial efforts and expands its IP portfolio. With 27 patents pending and 42 issued, BioStem has a strong portfolio across the wound care landscape that will protect the company as it forges ahead in the market. Clorox (SYM: CLX) Amazon just broke ground on a massive AI data center project in Canada. These facilities are critical to powering the next wave of AI innovation. But here's the real secret...A tiny, unknown company located just next door has the technology to supply the clean, uninterrupted power Amazon desperately needs for its expansion. Boxabl BOXABL Announces New $20,000 House Found this helpful? Share it with others. Written by Ian Cooper |
|---|
